{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009466","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2024-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.377963+00:00","generated_at":"2026-06-01T02:09:03.102119+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Fortress Biotech adopts bylaw amendments on director voting and exclusive forum","bullets":["Director election voting changed to majority of votes cast in uncontested elections, plurality in contested.","Directors failing to receive majority vote must promptly tender resignation; board may accept or reject.","Delaware designated as exclusive forum for certain disputes under the amended bylaws.","Amendments effective June 19, 2024, adopted by Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009466","json":"https://secwatch.observer/filing/0001558370-24-009466.json","markdown":"https://secwatch.observer/filing/0001558370-24-009466.md","text":"https://secwatch.observer/filing/0001558370-24-009466.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024009466/0001558370-24-009466-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024009466/fbio-20240619x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:09:03.102119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}